Literature DB >> 20200332

Family-based analysis of candidate genes for polycystic ovary syndrome.

Kathryn G Ewens1, Douglas R Stewart, Wendy Ankener, Margrit Urbanek, Jan M McAllister, Chen Chen, K Maravet Baig, Stephen C J Parker, Elliot H Margulies, Richard S Legro, Andrea Dunaif, Jerome F Strauss, Richard S Spielman.   

Abstract

CONTEXT: Polycystic ovary syndrome (PCOS) is a complex disorder having both genetic and environmental components. A number of association studies based on candidate genes have reported significant association, but few have been replicated. D19S884, a polymorphic marker in fibrillin 3 (FBN3), is one of the few association findings that has been replicated in independent sets of families.
OBJECTIVE: The aims of the study are: 1) to genotype single nucleotide polymorphisms (SNPs) in the region of D19S884; and 2) to follow up with an independent data set, published results reporting evidence for PCOS candidate gene associations.
DESIGN: The transmission disequilibrium test (TDT) was used to analyze linkage and association between PCOS and SNPs in candidate genes previously reported by us and by others as significantly associated with PCOS.
SETTING: The study was conducted at academic medical centers. PATIENTS OR OTHER PARTICIPANTS: A total of 453 families having a proband with PCOS participated in the study. Sisters with PCOS were also included. There was a total of 502 probands and sisters with PCOS. INTERVENTION(S): There were no interventions. MAIN OUTCOME MEASURE(S): The outcome measure was transmission frequency of SNP alleles.
RESULTS: We identified a six-SNP haplotype block spanning a 6.7-kb region on chromosome 19p13.2 that includes D19S884. SNP haplotype allele-C alone and in combination with D19S884-allele 8 is significantly associated with PCOS: haplotype-C TDT chi(2) = 10.0 (P = 0.0016) and haplotype-C/A8 TDT chi(2) = 7.6 (P = 0.006). SNPs in four of the other 26 putative candidate genes that were tested using the TDT were nominally significant (ACVR2A, POMC, FEM1B, and SGTA). One SNP in POMC (rs12473543, chi(2) = 9.1; P(corrected) = 0.042) is significant after correction for multiple testing.
CONCLUSIONS: A polymorphic variant, D19S884, in FBN3 is associated with risk of PCOS. POMC is also a candidate gene of interest.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20200332      PMCID: PMC2869537          DOI: 10.1210/jc.2009-2703

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  40 in total

1.  Merlin--rapid analysis of dense genetic maps using sparse gene flow trees.

Authors:  Gonçalo R Abecasis; Stacey S Cherny; William O Cookson; Lon R Cardon
Journal:  Nat Genet       Date:  2001-12-03       Impact factor: 38.330

2.  Association between the D19S884 marker at the insulin receptor gene locus and polycystic ovary syndrome.

Authors:  Gemma Villuendas; Héctor F Escobar-Morreale; Flavia Tosi; José Sancho; Paolo Moghetti; José L San Millán
Journal:  Fertil Steril       Date:  2003-01       Impact factor: 7.329

3.  Construction of a genome-scale structural map at single-nucleotide resolution.

Authors:  Jason A Greenbaum; Bo Pang; Thomas D Tullius
Journal:  Genome Res       Date:  2007-06       Impact factor: 9.043

4.  Follistatin regulates bone morphogenetic protein-7 (BMP-7) activity to stimulate embryonic muscle growth.

Authors:  Helge Amthor; Bodo Christ; Fiza Rashid-Doubell; C Fred Kemp; Emily Lang; Ketan Patel
Journal:  Dev Biol       Date:  2002-03-01       Impact factor: 3.582

5.  Evidence for association of polycystic ovary syndrome in caucasian women with a marker at the insulin receptor gene locus.

Authors:  S Tucci; W Futterweit; E S Concepcion; D A Greenberg; R Villanueva; T F Davies; Y Tomer
Journal:  J Clin Endocrinol Metab       Date:  2001-01       Impact factor: 5.958

6.  Latent transforming growth factor beta-binding protein 1 interacts with fibrillin and is a microfibril-associated protein.

Authors:  Zenzo Isogai; Robert N Ono; Shin Ushiro; Douglas R Keene; Yan Chen; Roberta Mazzieri; Noe L Charbonneau; Dieter P Reinhardt; Daniel B Rifkin; Lynn Y Sakai
Journal:  J Biol Chem       Date:  2002-11-11       Impact factor: 5.157

7.  Differential activity of the cytochrome P450 17alpha-hydroxylase and steroidogenic acute regulatory protein gene promoters in normal and polycystic ovary syndrome theca cells.

Authors:  J K Wickenheisser; P G Quinn; V L Nelson; R S Legro; J F Strauss; J M McAllister
Journal:  J Clin Endocrinol Metab       Date:  2000-06       Impact factor: 5.958

8.  Two exonic single nucleotide polymorphisms in the microsomal epoxide hydrolase gene are associated with polycystic ovary syndrome.

Authors:  Seija Korhonen; Eeva Liisa Romppanen; Mikko Hiltunen; Seppo Helisalmi; Kari Punnonen; Maritta Hippeläinen; Seppo Heinonen
Journal:  Fertil Steril       Date:  2003-06       Impact factor: 7.329

Review 9.  Genetic approaches to polycystic ovarian syndrome.

Authors:  Marie Nam Menke; Jerome F Strauss
Journal:  Curr Opin Obstet Gynecol       Date:  2007-08       Impact factor: 1.927

10.  Genetic and gene expression analyses of the polycystic ovary syndrome candidate gene fibrillin-3 and other fibrillin family members in human ovaries.

Authors:  Mark J Prodoehl; Nicholas Hatzirodos; Helen F Irving-Rodgers; Zhen Z Zhao; Jodie N Painter; Theresa E Hickey; Mark A Gibson; William E Rainey; Bruce R Carr; Helen D Mason; Robert J Norman; Grant W Montgomery; Raymond J Rodgers
Journal:  Mol Hum Reprod       Date:  2009-08-19       Impact factor: 4.025

View more
  45 in total

Review 1.  Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome.

Authors:  Selma F Witchel; Sergio E Recabarren; Frank González; Evanthia Diamanti-Kandarakis; Kai I Cheang; Antoni J Duleba; Richard S Legro; Roy Homburg; Renato Pasquali; Rogerio A Lobo; Christos C Zouboulis; Fahrettin Kelestimur; Franca Fruzzetti; Walter Futterweit; Robert J Norman; David H Abbott
Journal:  Endocrine       Date:  2012-06-04       Impact factor: 3.633

2.  Survival, growth, and maturation of secondary follicles from prepubertal, young, and older adult rhesus monkeys during encapsulated three-dimensional culture: effects of gonadotropins and insulin.

Authors:  Jing Xu; Marcelo P Bernuci; Maralee S Lawson; Richard R Yeoman; Thomas E Fisher; Mary B Zelinski; Richard L Stouffer
Journal:  Reproduction       Date:  2010-08-20       Impact factor: 3.906

3.  Fibrillin-3 expression in human development.

Authors:  Laetitia Sabatier; Nicolai Miosge; Dirk Hubmacher; Guoqing Lin; Elaine C Davis; Dieter P Reinhardt
Journal:  Matrix Biol       Date:  2010-10-21       Impact factor: 11.583

4.  Metabolic Evidence of Diminished Lipid Oxidation in Women With Polycystic Ovary Syndrome.

Authors:  Leah D Whigham; Daniel E Butz; Hesam Dashti; Marco Tonelli; Luann K Johnson; Mark E Cook; Warren P Porter; Hamid R Eghbalnia; John L Markley; Steven R Lindheim; Dale A Schoeller; David H Abbott; Fariba M Assadi-Porter
Journal:  Curr Metabolomics       Date:  2014

Review 5.  Ontogeny of polycystic ovary syndrome and insulin resistance in utero and early childhood.

Authors:  David H Abbott; Fida Bacha
Journal:  Fertil Steril       Date:  2013-07       Impact factor: 7.329

Review 6.  Primate follicular development and oocyte maturation in vitro.

Authors:  Jing Xu; Min Xu; Marcelo P Bernuci; Thomas E Fisher; Lonnie D Shea; Teresa K Woodruff; Mary B Zelinski; Richard L Stouffer
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

Review 7.  The genetic basis of female reproductive disorders: etiology and clinical testing.

Authors:  Lawrence C Layman
Journal:  Mol Cell Endocrinol       Date:  2013-03-14       Impact factor: 4.102

8.  Association study of androgen signaling pathway genes in polycystic ovary syndrome.

Authors:  Aline Ketefian; Michelle R Jones; Ronald M Krauss; Yii-Der I Chen; Richard S Legro; Ricardo Azziz; Mark O Goodarzi
Journal:  Fertil Steril       Date:  2015-10-20       Impact factor: 7.329

Review 9.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Authors:  Evanthia Diamanti-Kandarakis; Andrea Dunaif
Journal:  Endocr Rev       Date:  2012-10-12       Impact factor: 19.871

Review 10.  The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.

Authors:  Robert L Rosenfield; David A Ehrmann
Journal:  Endocr Rev       Date:  2016-07-26       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.